Kinnevik Investment


Babylon goes the SPAC route, Kinnevik to book SEK1.8bn in excess value

03/06/21 -"Following the holding company’s 31 May ad hoc announcement regarding a potential listing of Babylon Health, Kinnevik has just confirmed that the company will go public through a SPAC merger ..."

Pages
63
Language
English
Published on
03/06/21
You may also be interested by these reports :
10/11/25
Euronext posted solid Q3 results with double-digit revenue growth, though below our forecasts due to lower-than-expected volatility weighing on ...

07/11/25
Our EPS for 2025 was affected by lower operating results from direct private assets, leading us to cut our revenue forecasts and increase costs from ...

07/11/25
This release did not provide much information, given the recent disposal moves. The focus was thus on direct private assets, which performed well ...

06/11/25
Eurazeo has posted good figures for 9M-25, with a pick-up in both fundraising and realisations despite a difficult market. Although it has enjoyed a ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO